Logo image of IPI

INTREPID POTASH INC (IPI) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:IPI - US46121Y2019 - Common Stock

27.32 USD
+0.4 (+1.49%)
Last: 12/22/2025, 12:34:24 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to IPI. IPI was compared to 84 industry peers in the Chemicals industry. IPI has a great financial health rating, but its profitability evaluates not so good. IPI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year IPI was profitable.
In the past year IPI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: IPI reported negative net income in multiple years.
IPI had a positive operating cash flow in each of the past 5 years.
IPI Yearly Net Income VS EBIT VS OCF VS FCFIPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -31.70%, IPI is doing worse than 90.48% of the companies in the same industry.
IPI's Return On Equity of -39.83% is on the low side compared to the rest of the industry. IPI is outperformed by 76.19% of its industry peers.
IPI has a worse Return On Invested Capital (0.97%) than 70.24% of its industry peers.
Industry RankSector Rank
ROA -31.7%
ROE -39.83%
ROIC 0.97%
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
IPI Yearly ROA, ROE, ROICIPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

IPI has a worse Operating Margin (2.53%) than 69.05% of its industry peers.
IPI's Gross Margin of 16.80% is on the low side compared to the rest of the industry. IPI is outperformed by 70.24% of its industry peers.
In the last couple of years the Gross Margin of IPI has declined.
Industry RankSector Rank
OM 2.53%
PM (TTM) N/A
GM 16.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
IPI Yearly Profit, Operating, Gross MarginsIPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

IPI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, IPI has more shares outstanding
Compared to 5 years ago, IPI has less shares outstanding
The debt/assets ratio for IPI has been reduced compared to a year ago.
IPI Yearly Shares OutstandingIPI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
IPI Yearly Total Debt VS Total AssetsIPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.20 indicates that IPI is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.20, IPI is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
IPI has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
IPI's Debt to FCF ratio of 0.07 is amongst the best of the industry. IPI outperforms 98.81% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that IPI is not too dependend on debt financing.
IPI has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. IPI outperforms 97.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Altman-Z 2.2
ROIC/WACC0.06
WACC15.69%
IPI Yearly LT Debt VS Equity VS FCFIPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

IPI has a Current Ratio of 5.24. This indicates that IPI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IPI (5.24) is better than 95.24% of its industry peers.
A Quick Ratio of 2.62 indicates that IPI has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.62, IPI belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.24
Quick Ratio 2.62
IPI Yearly Current Assets VS Current LiabilitesIPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

4

3. Growth

3.1 Past

IPI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 212.00%, which is quite impressive.
The Revenue has grown by 8.88% in the past year. This is quite good.
Measured over the past years, IPI shows a small growth in Revenue. The Revenue has been growing by 2.96% on average per year.
EPS 1Y (TTM)212%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%178.57%
Revenue 1Y (TTM)8.88%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%-7.52%

3.2 Future

IPI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.60% yearly.
IPI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.05% yearly.
EPS Next Y373.82%
EPS Next 2Y35.34%
EPS Next 3Y21.6%
EPS Next 5YN/A
Revenue Next Year15.36%
Revenue Next 2Y1.35%
Revenue Next 3Y1.05%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IPI Yearly Revenue VS EstimatesIPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
IPI Yearly EPS VS EstimatesIPI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 32.52, which means the current valuation is very expensive for IPI.
Compared to the rest of the industry, the Price/Earnings ratio of IPI is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.39, IPI is valued a bit more expensive.
IPI is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 32.52
Fwd PE N/A
IPI Price Earnings VS Forward Price EarningsIPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

IPI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IPI is cheaper than 84.52% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IPI is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.13
EV/EBITDA 6.05
IPI Per share dataIPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IPI's earnings are expected to grow with 21.60% in the coming years.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y35.34%
EPS Next 3Y21.6%

0

5. Dividend

5.1 Amount

IPI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

INTREPID POTASH INC

NYSE:IPI (12/22/2025, 12:34:24 PM)

27.32

+0.4 (+1.49%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-02 2026-03-02/amc
Inst Owners63.17%
Inst Owner Change3.58%
Ins Owners1.98%
Ins Owner Change-1.82%
Market Cap366.91M
Revenue(TTM)278.25M
Net Income(TTM)-195.44M
Analysts42.22
Price Target23.46 (-14.13%)
Short Float %4.04%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)155.73%
Min EPS beat(2)-12.87%
Max EPS beat(2)324.33%
EPS beat(4)2
Avg EPS beat(4)260.43%
Min EPS beat(4)-142.02%
Max EPS beat(4)872.28%
EPS beat(8)2
Avg EPS beat(8)-45.42%
EPS beat(12)2
Avg EPS beat(12)-67.53%
EPS beat(16)3
Avg EPS beat(16)-55.99%
Revenue beat(2)2
Avg Revenue beat(2)16.21%
Min Revenue beat(2)6.36%
Max Revenue beat(2)26.05%
Revenue beat(4)4
Avg Revenue beat(4)14.89%
Min Revenue beat(4)6.36%
Max Revenue beat(4)26.05%
Revenue beat(8)8
Avg Revenue beat(8)20.17%
Revenue beat(12)12
Avg Revenue beat(12)22.88%
Revenue beat(16)15
Avg Revenue beat(16)18.37%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.66%
EPS NY rev (1m)-1.21%
EPS NY rev (3m)180.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.22%
Revenue NY rev (1m)12.7%
Revenue NY rev (3m)12.7%
Valuation
Industry RankSector Rank
PE 32.52
Fwd PE N/A
P/S 1.32
P/FCF 13.13
P/OCF 6.74
P/B 0.75
P/tB 0.79
EV/EBITDA 6.05
EPS(TTM)0.84
EY3.07%
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)2.08
FCFY7.62%
OCF(TTM)4.05
OCFY14.84%
SpS20.72
BVpS36.54
TBVpS34.78
PEG (NY)0.09
PEG (5Y)N/A
Graham Number26.28
Profitability
Industry RankSector Rank
ROA -31.7%
ROE -39.83%
ROCE 1.23%
ROIC 0.97%
ROICexc 1.12%
ROICexgc 1.18%
OM 2.53%
PM (TTM) N/A
GM 16.8%
FCFM 10.05%
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Debt/EBITDA 0.04
Cap/Depr 65.81%
Cap/Sales 9.52%
Interest Coverage 15.83
Cash Conversion 115.12%
Profit Quality N/A
Current Ratio 5.24
Quick Ratio 2.62
Altman-Z 2.2
F-Score5
WACC15.69%
ROIC/WACC0.06
Cap/Depr(3y)154.88%
Cap/Depr(5y)113.05%
Cap/Sales(3y)19.65%
Cap/Sales(5y)14.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)212%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%178.57%
EPS Next Y373.82%
EPS Next 2Y35.34%
EPS Next 3Y21.6%
EPS Next 5YN/A
Revenue 1Y (TTM)8.88%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%-7.52%
Revenue Next Year15.36%
Revenue Next 2Y1.35%
Revenue Next 3Y1.05%
Revenue Next 5YN/A
EBIT growth 1Y182.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1899.6%
EBIT Next 3Y139.3%
EBIT Next 5YN/A
FCF growth 1Y187.9%
FCF growth 3Y-17.26%
FCF growth 5YN/A
OCF growth 1Y-6.63%
OCF growth 3Y-2.86%
OCF growth 5Y7.97%

INTREPID POTASH INC / IPI FAQ

What is the fundamental rating for IPI stock?

ChartMill assigns a fundamental rating of 4 / 10 to IPI.


What is the valuation status of INTREPID POTASH INC (IPI) stock?

ChartMill assigns a valuation rating of 4 / 10 to INTREPID POTASH INC (IPI). This can be considered as Fairly Valued.


What is the profitability of IPI stock?

INTREPID POTASH INC (IPI) has a profitability rating of 2 / 10.


What is the financial health of INTREPID POTASH INC (IPI) stock?

The financial health rating of INTREPID POTASH INC (IPI) is 8 / 10.


What is the expected EPS growth for INTREPID POTASH INC (IPI) stock?

The Earnings per Share (EPS) of INTREPID POTASH INC (IPI) is expected to grow by 373.82% in the next year.